MedTrace Logo

Fibromyalgia Syndrome on Patients With Chronic Migraine

NCT05381012 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-09-28

No results posted yet for this study

Summary

The aim of this study to evaluate the effects of fibromyalgia syndrome accompanying women with chronic migraine on pain, quality of life, sleep, anxiety and depression, central sensitization and functionality.

Conditions

  • Chronic Migraine, Headache
  • Fibromyalgia Syndrome
  • Chronic Pain Syndrome
  • Central Sensitisation
  • Headache Disorders

Interventions

OTHER

Allodynia, quality of life, sleep, anxiety and depression, disability, and central sensitization

All patients will be evaluated for allodynia, quality of life, sleep, anxiety and depression, disability related to headache, and central sensitization.

OTHER

Fibromyalgia syndrome

Patients who meet the diagnostic criteria for fibromyalgia syndrome will be evaluated with the Fibromyalgia Impact Questionnaire.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Uğur Uygunoğlu, MD · Istanbul University - Cerrahpasa

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05381012 on ClinicalTrials.gov